June 4, 2020 / 12:05 PM / 2 months ago

BRIEF-Jounce Therapeutics Regains Worldwide Rights To JTX-8064 From Bristol Myers Squibb

June 4 (Reuters) - Jounce Therapeutics Inc:

* JOUNCE THERAPEUTICS REGAINS WORLDWIDE RIGHTS TO JTX-8064 FROM BRISTOL MYERS SQUIBB

* JOUNCE THERAPEUTICS INC - BRISTOL MYERS SQUIBB NOTIFIED JOUNCE THAT JTX-8064 LICENSE AGREEMENT IS BEING TERMINATED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below